Shin Poong Pharm.Co.,Ltd. (019175.KS)

KRW 16370.0

(-3.14%)

Market Cap (In KRW)

549.25 Billion

Revenue (In KRW)

200.22 Billion

Net Income (In KRW)

-57.32 Billion

Avg. Volume

11.74 Thousand

Currency
KRW
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
15350.0-39400.0
PE
-
EPS
-
Beta Value
0.815
ISIN
KR7019171008
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Jei-Man Ryu
Employee Count
-
Website
https://shinpoong.co.kr
Ipo Date
2005-09-29
Details
Shin Poong Pharm.Co.,Ltd. manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products. It also provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; and over the counter products. The company also exports its products to approximately 50 countries. Shin Poong Pharm.Co.,Ltd. was founded in 1962 and is headquartered in Seoul, South Korea.